Dr. Michael Cantor Named Intuition Robotics 1st Chief Medical Officer

Dr. Michael Cantor will bring his expertise both as a geriatrician and as the former Chief Medical Officer of Bright Health Plan, a Medicare Advantage insurer, to aid the company’s efforts in leveraging ElliQ to bring care to older adults into their homes.

The company recently announced its plan to extend to healthcare.

Before joining Intuition Robotics, Dr. Michael Cantor was the Chief Medical Officer at Bright Health Plan, where he liaised with their network of doctors, clinics and hospitals to provide the best healthcare possible. Before Bright, he was Chief Medical Officer for home healthcare company, CareCentrix, where he worked with payors and providers to create programs that improve quality and lower costs by allowing patients to heal and age at home. Prior to that, he was also the Chief Medical Officer for New England Quality Care Alliance and the New England Deputy Medical Director for UnitedHealthcare.

Dr. Cantor trained in primary care internal medicine and geriatrics at Beth Israel Hospital/Harvard Medical School. He has degrees in law and medicine from the University of Illinois.

The Covid-19 pandemic has accelerated the demand for both in-home and virtual care, especially for older adults. ElliQ’s unique and constant presence in the home, combined with the engagement levels the company has been seeing over the past few years, led the company to seek out a Chief Medical Officer to enhance their offering within the health space.

In his role as Chief Medical Officer, Dr. Michael Cantor will assist in designing ElliQ’s capabilities, working alongside clinical teams to help them deliver better in-home care — liaising between the older adult ElliQ users and the healthcare ecosystem. Dr. Cantor will work closely with physicians to understand the best way to incorporate ElliQ into pathways of care, and how ElliQ can help them effectively improve the quality of their care.

“I’m excited to be joining a company that brings care to the patient, rather than bringing the patient to the care, especially when it comes to older adults,” says Dr. Michael Cantor, MD, Chief Medical Officer of Intuition Robotics. “As a geriatrician, I appreciate how ElliQ allows older adults to age in place by creating stronger connections to the outside world. By adding additional health features to ElliQ, we can holistically support the older adult population by providing social companionship and enhancing relationships with their clinical team.”

“The pandemic showed the importance and challenges of delivering care at home to older adults. It became immediately clear that having ElliQ work together with care teams will dramatically improve the quality of care,” says Dor Skuler, CEO and Co-founder of Intuition Robotics. “We’re thrilled that someone with Dr. Cantor’s level of experience decided to join our company and help us extend ElliQ into healthcare. Dr. Cantor brings vast understanding in geriatric medicine that will no doubt prove crucial to our success.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”